Suppr超能文献

特非那定与安慰剂治疗慢性特发性荨麻疹的比较:一项随机双盲研究。

Terfenadine and placebo compared in the treatment of chronic idiopathic urticaria: a randomised double-blind study.

作者信息

Ferguson J, MacDonald K J, Kenicer K J

出版信息

Br J Clin Pharmacol. 1985 Dec;20(6):639-41. doi: 10.1111/j.1365-2125.1985.tb05122.x.

Abstract

Terfenadine, a potent and non-sedative antihistamine, was shown to be effective in chronic idiopathic urticaria in a double-blind crossover placebo controlled trial. An oral twice daily 60 mg dose of terfenadine was given and itch and wheal parameters were assessed daily. Despite the overall effectiveness of terfenadine, a variable response was noted which was similar to that shown in previous studies with other antihistamines.

摘要

特非那定是一种强效非镇静性抗组胺药,在一项双盲交叉安慰剂对照试验中显示对慢性特发性荨麻疹有效。给予每日两次口服60毫克特非那定的剂量,并每天评估瘙痒和风团参数。尽管特非那定总体有效,但仍观察到个体反应存在差异,这与先前使用其他抗组胺药的研究结果相似。

相似文献

2
Treatment of chronic idiopathic urticaria with terfenadine.
Clin Allergy. 1984 Mar;14(2):139-41. doi: 10.1111/j.1365-2222.1984.tb02644.x.

本文引用的文献

1
The pathogenic basis of urticaria and angioedema: recent advances.
Am J Med. 1981 Apr;70(4):755-8. doi: 10.1016/0002-9343(81)90528-3.
2
Treatment of chronic idiopathic urticaria with terfenadine.
Clin Allergy. 1984 Mar;14(2):139-41. doi: 10.1111/j.1365-2222.1984.tb02644.x.
3
Sedation and antihistaminics.
Arzneimittelforschung. 1982;32(9a):1193-5.
4
Terfenadine, the first non-sedating antihistamine.
Arzneimittelforschung. 1982;32(9a):1154-6.
7
Urticaria and angio-oedema. A review of 554 patients.荨麻疹和血管性水肿。对554例患者的回顾。
Br J Dermatol. 1969 Aug;81(8):588-97. doi: 10.1111/j.1365-2133.1969.tb16041.x.
8
Assessment of tissue fluid histamine levels in patients with urticaria.荨麻疹患者组织液组胺水平的评估。
J Allergy Clin Immunol. 1978 Jun;61(6):350-4. doi: 10.1016/0091-6749(78)90113-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验